Lu Yang
Impact in
-
- Lung Cancer Treatments and Mutations
- Ferroptosis and cancer prognosis
- Lung Cancer Diagnosis and Treatment
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 40
- Ferroptosis and cancer prognosis 3
- Oncology 29
- Lung Cancer Research Studies 9
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 5
- Peptidase Inhibition and Analysis 3
- Co-authors
- Hua Bai (15 shared papers)Jie Wang (11 shared papers)Yan Wang (25 shared papers)Jinhua Xu (2 shared papers)Yanhong Shou (2 shared papers)Yongsheng Yang (2 shared papers)Haiyan Xu (23 shared papers)Meina Wu (14 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Medicine (6 papers)Lung Cancer (5 papers)Frontiers in Oncology (3 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Lu Yang
94 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 105
- Pulmonary and Respiratory Medicine 1.0k
- Cancer Research 471
- Oncology 672
- Immunology 187
- Molecular Biology 499
Countries citing papers authored by Lu Yang
This map shows the geographic impact of Lu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Yang more than expected).
Fields of papers citing papers by Lu Yang
This network shows the impact of papers produced by Lu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Yang. The network helps show where Lu Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 232 | |
| 2 | 2012 | 166 | |
| 3 | 2021 | 152 | |
| 4 | 2022 | 108 | |
| 5 | 2010 | 83 | |
| 6 | 2013 | 83 | |
| 7 | 2020 | 76 | |
| 8 | 2017 | 62 | |
| 9 | 2022 | 58 | |
| 10 | 2023 | 47 | |
| 11 | 2009 | 47 | |
| 12 | 2019 | 44 | |
| 13 | 2012 | 42 | |
| 14 | 2016 | 41 | |
| 15 | 2012 | 40 | |
| 16 | 2011 | 40 | |
| 17 | 2022 | 40 | |
| 18 | 2020 | 36 | |
| 19 | 2012 | 36 | |
| 20 | 2022 | 35 |
About Lu Yang
Lu Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 101 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (40 papers), Lung Cancer Research Studies (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Treatments and Studies (5 papers), Peptidase Inhibition and Analysis (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.0k citations), Cancer Research (471 citations), Oncology (672 citations), Immunology (187 citations) and Molecular Biology (499 citations). Lu Yang has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Hua Bai, Jie Wang, Yan Wang, Jinhua Xu, Yanhong Shou, Yongsheng Yang, Haiyan Xu, Meina Wu, Tongtong An and Jun Zhao. Their work appears in journals such as Journal of Clinical Oncology, Cancer Medicine, Lung Cancer, Frontiers in Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.